GB-115 effects The gb115 peptide, also known by its chemical name N-(6-phenylhexanoyl)glycyl-L-tryptophan amide and the brand name Ranquilon, is a novel dipeptide compound that has garnered significant attention for its anxiolytic properties. Developed as a selective antagonist of central cholecystokinin-1 (CCK-1) receptors, GB-115 represents a promising therapeutic agent for various conditions, particularly anxiety disorders. Its mechanism of action, distinct from traditional benzodiazepines, offers a potential alternative with a different side-effect profile.作者：GW Anderson·1967·被引用次数：588—N‐MethylatedPeptideSynthesis via Generation of an Acyl N‐Methylimidazolium ... Synthesis of substituted dipeptideGB-115as a potential selective anxiolytic. Beyond its primary role in anxiety treatment, research has also explored its anti-inflammatory effects and impact on cognitive processes.N-METHYL PEPTIDES. - AUBRY - 1981
GB-115 functions by targeting and blocking the activity of cholecystokinin-1 receptors in the central nervous system. Cholecystokinin (CCK) is a neuropeptide that plays a role in a variety of physiological processes, including satiety, pain perception, and anxiety.GB-115 - Spray Solution (2mg/mL) By antagonizing CCK-1 receptors, GB-115 is believed to modulate neural pathways associated with fear and stress responsesSynthesis of substituted dipeptide GB115 as a potential .... This selective action differentiates it from broader-acting anxiolytics, potentially leading to a more targeted therapeutic effect作者：EV Shipaeva·2011·被引用次数：1—Anti-inflammatory effects ofGB-115compound (N-phenylhexanoyl-glycyl-L-tryptophan amide) injected intraperitoneally in doses of 0.1, 1, and 10 mg/kg were .... Studies suggest that its anxiolytic action is accompanied by mild psychostimulant properties, which may contribute to its effectiveness in managing generalized anxiety disorder (GAD).
The primary clinical interest in the GB-115 peptide lies in its potential to treat anxiety disorders2025年8月6日—A chromatographic method for quantitative determination of thepeptidesubstanceGB-115with anxiolytic activity was developed.. Clinical trials have investigated its efficacy and safety in patients suffering from anxiety. One notable study focused on its impact on cognitive processes in patients with GAD, suggesting a positive influence beyond just symptom reduction. The development of Ranquilon, the brand name under which GB-115 has been approved in Russia, underscores its progression from preclinical research to clinical applicationStudy of anti-inflammatory effects of GB-115, a glycine- .... Further investigations are ongoing, including studies examining its role in managing anxiety within specific clinical trial contexts.
While anxiety treatment is the most prominent application, the GB-115 peptide has also demonstrated other notable effects.作者：TA Gudasheva·2018·被引用次数：39—GB 115, A SELECTIVE DIPEPTIDE ANXIOLYTIC. The classical strategy “from the endogenouspeptideto the drug” was used for design of selective dipeptide anxiolytic ... Research has indicated anti-inflammatory properties, with studies showing a significant alleviation of experimental autoimmune encephalomyelitis in mice following intraperitoneal injection of GB-115.Peptide· Cell Cycle · Anti-infection · Autophagy · Cytoskeletal Signaling · DNA Damage · Dye Reagent · Proteins · NF-κB · PI3K/Akt/mTOR · Proteases · Protein ... This suggests a broader therapeutic scope that could extend to inflammatory and autoimmune conditions.作者：EV Ivannikova·2013—Quantitative Determination of thePeptide GB-115in Biological Media by HPLC/MS ... A chromatographic method for quantitative determination of the ... Furthermore, its influence on emotional stress reactions and the restoration of adaptive behavior in preclinical models has been observed, indicating potential benefits in managing stress-related conditions.
Understanding the pharmacokinetic profile of GB-115 is crucial for its effective clinical use. Studies have evaluated its absorption, distribution, metabolism, and excretion in various species, including rats, rabbits, and human volunteers.Preclinical and Clinical Pharmacokinetics of a ... - J-Stage Developing precise analytical methods for quantifying the GB-115 peptide in biological media is essential for pharmacokinetic studies and therapeutic drug monitoring. Chromatographic techniques, such as HPLC/MS, have been employed to achieve this quantitative determination, ensuring the accuracy and reliability of research findings.
The GB-115 peptide represents an exciting development in the field of neuropharmacology. Its selective mechanism of action as a CCK-1 receptor antagonist offers a novel approach to managing anxiety and potentially other conditions. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential, refine dosing strategies, and further characterize its safety profile作者：PO Bochkov·2018—The aim of this study was to evaluateGB-115pharmacokinetics in rats, rabbits and volunteers. Methods.GB-115- C6H5-(CH2)5CO-Gly-Trp-NH2 is .... As a dipeptide compound, it also highlights the growing importance of peptide-based therapeutics in modern medicine. The development of efficient synthesis methods for peptides like GB-115 is also an active area of research, aiming to make these potentially life-changing compounds more accessible.
Join the newsletter to receive news, updates, new products and freebies in your inbox.